Skip to main content
Home
    • en
    • fr
  • Search form

Main menu

  • About us
    • Our mission
    • Facts & Figures
    • Our Strategy
    • Corporate Governance/ Executive Committee
    • bioMérieux Worldwide
    • Our History
    • Innovation
    • Institut Mérieux

  • Responsibility
    • Our ambition
    • Health
    • Planet
    • Healthcare ecosystem
    • Employees
    • Extended Company
    • SantéRESISTANCE TO ANTIBIOTICS
    • PlanèteCOVID-19 EXCEPTIONAL DONATIONS
  • Solutions
    • Clinical Solutions
    • Industry Solutions
    • Product Quality & Safety
    • Customer Service
    • Cybersecurity
    • Technical Library
    • CLINICAL SOLUTIONS
    • INDUSTRY SOLUTIONS
  • Expertise
    • The importance of diagnostics
      • Clinical diagnostics
      • Industrial Microbiological Control
    • Clinical applications
      • Infectious diseases
      • COVID-19
      • Antimicrobial resistance and Healthcare-associated infections
      • Cardiovascular Emergencies
      • Personalized medicine
    • Industrial applications
      • Agri-food sector
      • Biopharma & cosmetics sectors
    • Our technologies, systems and services
      • Microbiology
      • Molecular Biology
      • Immunoassays
      • Services
    • Glossary of Scientific Terms
  • Education
    • Antimicrobial Resistance / Antimicrobial Stewardship
      • Webinars
      • Educational Materials
      • External Resources
    • Sepsis / Bloodstream Infections
      • Webinars
      • Educational Tutorials
      • Educational Materials
      • External Resources
    • COVID-19
      • Webinars
    • Acute Kidney Injury
      • Webinars & Symposiums
      • Educational Materials
      • External Resources
    • Cardiac Emergencies
      • Educational Tutorials
      • Educational Materials
    • Educational booklets
  • Investors
    • The bioMérieux Share
    • Publications
    • Regulated Information
    • Governance
    • Shareholder area
    • UNIVERSAL REGISTRATION DOCUMENT
    • CORPORATE SOCIAL RESPONSIBILITY
  • Newsroom
    • Press Releases
    • Corporate calendar
    • Media Center
    • About bioMérieux
    • bioMérieux announces the CE marking of 3 dengue immunoessays on VIDAS®
    • PRESS CONTACTS
     
  • Careers
    • Joining bioMérieux
      • Corporate culture
      • Public health mission
      • International presence
      • Professional development
      • Diversity and inclusion
      • Well-being at work
      • Compensation and benefits
    • Job Profiles
      • R&D
      • Manufacturing
      • Supply Chain
      • Information Systems
      • Quality
      • Business
      • Support Functions
      • Medical Affairs
      • HSE
      • Clinical Affairs and Regulatory Affairs
  • Contact us
Home
  • About us
    • Our mission
    • Facts & Figures
    • Our Strategy
    • Corporate Governance/ Executive Committee
    • bioMérieux Worldwide
    • Our History
    • Innovation
    • Institut Mérieux
  • Responsibility
    • Our ambition
    • Health
    • Planet
    • Healthcare ecosystem
    • Employees
    • Extended Company
  • Solutions
    • Clinical Solutions
    • Industry Solutions
    • Product Quality & Safety
    • Customer Service
    • Cybersecurity
    • Technical Library
  • Expertise
    • The importance of diagnostics
    • Clinical applications
    • Industrial applications
    • Our technologies, systems and services
    • Glossary of Scientific Terms
  • Education
    • Antimicrobial Resistance / Antimicrobial Stewardship
    • Sepsis / Bloodstream Infections
    • COVID-19
    • Acute Kidney Injury
    • Cardiac Emergencies
    • Educational booklets
  • Investors
    • The bioMérieux Share
    • Publications
    • Regulated Information
    • Governance
    • Shareholder area
  • Newsroom
    • Press Releases
    • Corporate calendar
    • Media Center
    • About bioMérieux
  • Careers
    • Joining bioMérieux
    • Job Profiles
  • Contact us
    • Investor Relations
    • Press Contacts
    • en
    • fr
  • Search form

bioMérieux Corporate Website | Pioneering diagnostics

Philanthropy

Covid-19 Exceptional Donations: discover the actions supported by bioMérieux to help people made vulnerable by the health crisis.

Gender Equality

bioMérieux is part of the Top 100 of Equileap's global ranking!

Top Employer 2021    

Discover the complete list of our certifications!

Investors

Discover our investors-dedicated section

Press releases
  • April 07, 2021 bioMérieux announces the CE marking of 3 dengue immunoassays on VI...
  • March 24, 2021 bioMérieux announces the CE marking of TB IGRA® test on VIDAS®  ...
  • March 18, 2021 BIOFIRE® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 obtains De ...
  • March 09, 2021 The Biotech Digital Campus joins forces with biotechnology schools ...
Pioneering diagnostics
  • Legal Notice
  • Privacy
  • Cookie Policy
  • Contact
  • Copyright 2020 bioMérieux SA
  • biomerieux.com
  • bioMérieux Worldwide >
    Discover all our locations
    Asia
    • China (Website)
    • India (Website)
    • Indonesia (website)
    • Japan (Website)
    • Korea
    • Malaysia (website)
    • Philippines (website)
    • Singapore (Website)
    • Thailand (website)
    • Vietnam (website)
    Europe, Middle East, Africa
    • Algeria
    • Austria (Website)
    • Belgium
    • Czech Republic (Website)
    • Denmark (Website)
    • Finland (Website)
    • France (Website)
    • Germany (Website)
    • Greece
    • Hungary (Website)
    • Italy (Website)
    • Ivory Coast
    • Netherlands
    • Norway (Website)
    • Poland (Website)
    • Portugal (Website)
    • Russia (Website)
    • Serbia
    • South Africa (Website)
    • Spain (Website)
    • Sweden (Website)
    • Switzerland (Website)
    • Turkey (Website)
    • United Arab Emirates
    • United Kingdom (Website)
    North America
    • Canada (Website)
    • United States (Website)
    Oceania
    • Australia (Website)
    • New Zealand (Website)
    South America
    • Argentina (Website)
    • Brazil (Website)
    • Chile (Website)
    • Colombia (Website)
    • Mexico (Website)
  • Our Specific Websites >
    • Antimicrobial Resistance Website
    • BioFire Diagnostics
    • bioMérieux Clinical Diagnostics
    • bioMérieux Industry
    • bioMérieux Investors
    • bioMérieux Recruitment
    • bioMérieux Culture Media
  • Our communities >
    • mybiomerieux.com